In astrocytomas, a significantly higher percentage of cells expressing Bcl-xL protein compared to Bcl-2 protein was found, whereas a reverse trend was observed in oligodendrogliomas [56]. The gene discussed is BCL2; the disease is astrocytoma (excluding glioblastoma).